Additionally, an intriguing pre-clinical observation made in immune-competent mice challenged with melanoma demonstrates that acquired resistance to immune checkpoint blockade is reversed by inhibiting JAK1/JAK2 signaling48. This evidence concerns the gene JAK1 and melanoma.